HCFA Coverage and Analysis Group
This article was originally published in The Gray Sheet
Executive Summary
Hugh Hill, MD, will serve as interim acting director for the coverage group, effective immediately following the departure of Grant Bagley, MD, at the end of the month. Hill is a member of the Johns Hopkins University faculty, but currently is serving under a government exchange program as a medical officer in the Health Care Financing Administration's Center for Health Plans and Providers. While Hill was appointed in June by Administrator Nancy-Ann DeParle to chair HCFA's Physician Regulatory Review Issues Team, he has only worked full time at CHPP for the last several months. HCFA intends to mount a nation-wide search for a permanent replacement to Bagley, who recently signed on with the Washington, D.C. law firm Arnold & Porter (1"The Gray Sheet" Nov. 1, p. 4)
You may also be interested in...
HCFA Coverage Group Loses Chief Bagley To Arnold & Porter
A permanent replacement for Coverage and Analysis Group Director Grant Bagley, MD, likely will need to have a medical degree, the Health Care Financing Administration official observed after announcing his departure from the agency the week of Oct. 25.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.